Processa Pharmaceuticals, Inc. (39) | Intellectual Property (9)
Browse by Subcategory
Recent Contracts
-
License Agreement dated June 16, 2021
(Filed With SEC on June 17, 2021)
-
Addendum No. 1 to the Aposense Ltd. License Agreement
(Filed With SEC on March 25, 2021)
-
License Option Agreement with CoNCERT
(Filed With SEC on September 17, 2020)
-
License Agreement with Akashi Therapeutics, Inc. dated August 29, 2019
(Filed With SEC on September 17, 2020)
-
License Agreement with Aposense, Ltd. dated May 24, 2020
(Filed With SEC on September 17, 2020)
-
License Agreement with Yuhan Corporation
(Filed With SEC on September 17, 2020)
-
License Agreement with Elion Oncology, Inc
(Filed With SEC on September 17, 2020)
-
License Agreement by and between Processa Pharmaceuticals and Elion Oncology dated August 23, 2020
(Filed With SEC on August 27, 2020)
-
License Agreement by and between Processa Pharmaceuticals, Inc. and Yuhan Corporation, dated August 19, 2020
(Filed With SEC on August 20, 2020)
